Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature. 2013 Dec 05; 504(7478):138-42.
View in:
PubMed
subject areas
Antineoplastic Agents
Cell Line, Tumor
Cell Lineage
CREB-Binding Protein
Cyclic AMP
Drug Resistance, Neoplasm
Gene Expression Regulation, Neoplastic
HEK293 Cells
Humans
Melanocytes
Melanoma
Mitogen-Activated Protein Kinases
Protein Kinase Inhibitors
Signal Transduction
Transcription Factors
authors with profiles
Keith Thomas Flaherty, M.D.